ClinConnect ClinConnect Logo
Search / Trial NCT06155058

Robotic Versus Conventional Therapy For Post-Stroke Hand Motoric Recovery

Launched by HASANUDDIN UNIVERSITY · Nov 24, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Robotic Therapy Mirror Therapy Post Stroke Upper Extremities Motoric Function Functional Outcome

ClinConnect Summary

This clinical trial is studying two different methods to help patients recover hand movement after a stroke: robotic therapy and mirror therapy. The goal is to see which method works better over time in helping patients regain use of their hands and improve their daily activities. Participants will be divided into two groups, with one group receiving robotic therapy and the other receiving mirror therapy, and researchers will check in regularly to assess their progress.

To be eligible for this trial, participants should be between 20 and 85 years old, have had a non-bleeding stroke at least three months prior, and have difficulty moving one arm. They also need to be able to understand the study and have had imaging of their brain after the stroke. Those with severe muscle tightness or other serious health issues that could affect their ability to participate will not be included. Participants can expect regular follow-ups to evaluate their recovery, and they need to attend the training sessions consistently to remain in the study.

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • 1. Patients aged 20 - 85 years.
  • 2. Non-haemorrhagic stroke/infarction with onset more than 3 months from the onset of the attack.
  • 3. Patients with unilateral upper limb hemiparesis.
  • 4. Modified Ashworth Scale (MAS) on fingers and hands \<3
  • 5. The patient has not undergone mirror therapy treatment before.
  • 6. Patients who are able to understand informed consent to participate in research.
  • 7. The patient had a Radiology imaging of the head at the time of stroke onset.
  • Exclusion criteria:
  • 1. Patients with severe spasticity or contractures of the upper extremities.
  • 2. Patients with infarction/bleeding with extensive lesions covering 2 hemispheres.
  • 3. The patient has severe cognitive impairment that will interfere with the research objectives (MMSE score \>24).
  • 4. Patients post Digital Subtraction Angiography (DSA) procedures in the last 2 months.
  • 5. Patients with a history of seizures or epilepsy.
  • 6. Patients with visual field deficits or severe visual impairment.
  • 7. Patients who are unable to sit upright without assistance.
  • 8. Other uncontrolled medical conditions (musculoskeletal, neuromuscular, cardiorespiratory) that may interfere with the ability to exercise.
  • Dropout criteria:
  • Patients were excluded from the study if:
  • 1. Participant dies.
  • 2. Participants take part in the exercise \<3 times for 2 consecutive weeks.
  • 3. The participant refuses to continue the training session.
  • 4. Participants experience hemodynamic disorders during the training program phase.
  • 5. Participants experience neurological disorders during the training program phase.

About Hasanuddin University

Hasanuddin University is a prestigious academic institution based in Indonesia, dedicated to advancing healthcare research and education. As a clinical trial sponsor, the university leverages its extensive expertise in medical and health sciences to conduct innovative research aimed at improving patient outcomes and addressing public health challenges. With a commitment to ethical research practices and collaboration with local and international partners, Hasanuddin University plays a vital role in contributing to the body of knowledge in clinical sciences, fostering advancements in treatment methodologies, and enhancing healthcare delivery in the region.

Locations

Makassar, South Sulawesi, Indonesia

Makassar, South Sulawesi, Indonesia

Makassar, South Sulawesi, Indonesia

Patients applied

0 patients applied

Trial Officials

Steven Kurniawan, MD

Principal Investigator

Hasanuddin University

Nuralam Sam, MD. Ph.D

Principal Investigator

Hasanuddin University

Husnul Mubarak, MD

Principal Investigator

Hasanuddin University

Yose Waluyo, MD. PhD

Principal Investigator

Hasanuddin University

Andi A Zainuddin, MD.Phd

Principal Investigator

Hasanuddin University

Andi A Mochtar, Dr. Eng

Principal Investigator

Hasanuddin University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported